KCTD9 and colorectal carcinoma: Collectively these data propose that KCTD9 inhibits the EMT in CRC cells by inhibition of Wnt signaling with loss of KCTD9 resulting in the redistribution of β-catenin to the nucleus with ensuing Wnt activation.